Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors

PURPOSE: Sphingosine kinase 1 (SK1) is a protooncogenic enzyme expressed in many human tumours and is associated with chemoresistance and poor prognosis. It is a potent therapy target and its inhibition chemosensitises solid tumours. Despite recent advances in SK1 inhibitors synthesis and validation...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshaker, Heba, Srivats, Shyam, Monteil, Danielle, Wang, Qi, Low, Caroline M. R., Pchejetski, Dmitri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208908/
https://www.ncbi.nlm.nih.gov/pubmed/30043096
http://dx.doi.org/10.1007/s10549-018-4900-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208908/
https://www.ncbi.nlm.nih.gov/pubmed/30043096
http://dx.doi.org/10.1007/s10549-018-4900-1

Ejemplares similares